A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

作者: Aminah Jatoi , James R. Jett , Jeff Sloan , Paul Novotny , Joyce Ford

DOI: 10.1007/S00520-004-0638-X

关键词:

摘要: Background Weight loss predicts a poor prognosis for patients with non-small-cell lung cancer. Tumor necrosis factor α (TNFα) is mediator of this weight loss, yet no studies have tested infliximab, an IgG monoclonal antibody that blocks the binding TNFα to its p55 and p75 receptors, indication. The safety pharmacokinetics infliximab in combination docetaxel, commonly used chemotherapy agent cancer, were explored pilot study.

参考文章(25)
D M Finkelstein, D S Ettinger, J C Ruckdeschel, Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. Journal of Clinical Oncology. ,vol. 4, pp. 702- 709 ,(1986) , 10.1200/JCO.1986.4.5.702
Branislav Jeremic, Biljana Milicic, Aleksandar Dagovic, Jasna Aleksandrovic, Nebojsa Nikolic, Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy Journal of Cancer Research and Clinical Oncology. ,vol. 129, pp. 114- 122 ,(2003) , 10.1007/S00432-002-0408-4
E Rapp, J L Pater, A Willan, Y Cormier, N Murray, W K Evans, D I Hodson, D A Clark, R Feld, A M Arnold, Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Journal of Clinical Oncology. ,vol. 6, pp. 633- 641 ,(1988) , 10.1200/JCO.1988.6.4.633
Diana Medgyesy, Jaffer A. Ajani, Yvonne Lassere, Paulo M. Hoff, Everardo D. Saad, Mark Russo, Sunita Dwivedy, Cynthia Wenske, Richard Pazdur, Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors. Clinical Cancer Research. ,vol. 9, pp. 134- 142 ,(2003)
Eduardo Bruera, Florian Strasser, J. Lynn Palmer, Jie Willey, Kathryn Calder, Gail Amyotte, Vickie Baracos, Effect of Fish Oil on Appetite and Other Symptoms in Patients With Advanced Cancer and Anorexia/Cachexia: A Double-Blind, Placebo-Controlled Study Journal of Clinical Oncology. ,vol. 21, pp. 129- 134 ,(2003) , 10.1200/JCO.2003.01.101
C. L. Loprinzi, N. M. Ellison, D. J. Schaid, J. E. Krook, L. M. Athmann, A. M. Dose, J. A. Mailliard, P. S. Johnson, L. P. Ebbert, L. H. Geeraerts, Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia Journal of the National Cancer Institute. ,vol. 82, pp. 1127- 1132 ,(1990) , 10.1093/JNCI/82.13.1127
Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S. Smolen, Diana Davis, John D. MacFarlane, Christian Antoni, Burkhard Leeb, Michael J. Elliott, James N. Woody, Thomas F. Schaible, Marc Feldmann, Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 41, pp. 1552- 1563 ,(1998) , 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W
Marta Llovera, Cèlia Garcı́a-Martı́nez, Joaquı́n López-Soriano, Neus Carbó, Neus Agell, Francisco J López-Soriano, Josep M Argiles, Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice Molecular and Cellular Endocrinology. ,vol. 142, pp. 183- 189 ,(1998) , 10.1016/S0303-7207(98)00105-1
Joan H. Schiller, David Harrington, Chandra P. Belani, Corey Langer, Alan Sandler, James Krook, Junming Zhu, David H. Johnson, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. The New England Journal of Medicine. ,vol. 346, pp. 92- 98 ,(2002) , 10.1056/NEJMOA011954
Branislav Jeremic, Biljana Milicic, Danica Grujicic, Aleksandar Dagovic, Jasna Aleksandrovic, Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. Journal of Cancer Research and Clinical Oncology. ,vol. 129, pp. 477- 484 ,(2003) , 10.1007/S00432-003-0471-5